These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30344906)

  • 1. Series of Alkynyl-Substituted Thienopyrimidines as Inhibitors of Protozoan Parasite Proliferation.
    Woodring JL; Behera R; Sharma A; Wiedeman J; Patel G; Singh B; Guyett P; Amata E; Erath J; Roncal N; Penn E; Leed SE; Rodriguez A; Sciotti RJ; Mensa-Wilmot K; Pollastri MP
    ACS Med Chem Lett; 2018 Oct; 9(10):996-1001. PubMed ID: 30344906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiparasitic Lead Discovery: Toward Optimization of a Chemotype with Activity Against Multiple Protozoan Parasites.
    Devine W; Thomas SM; Erath J; Bachovchin KA; Lee PJ; Leed SE; Rodriguez A; Sciotti RJ; Mensa-Wilmot K; Pollastri MP
    ACS Med Chem Lett; 2017 Mar; 8(3):350-354. PubMed ID: 28337329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EVALUATION OF AROMATIC 6-SUBSTITUTED THIENOPYRIMIDINES AS SCAFFOLDS AGAINST PARASITES THAT CAUSE TRYPANOSOMIASIS, LEISHMANIASIS, AND MALARIA.
    Woodring JL; Patel G; Erath J; Behera R; Lee PJ; Leed SE; Rodriguez A; Sciotti RJ; Mensa-Wilmot K; Pollastri MP
    Medchemcomm; 2015 Feb; 6(2):339-346. PubMed ID: 25685309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation.
    Woodring JL; Bachovchin KA; Brady KG; Gallerstein MF; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Pollastri MP
    Eur J Med Chem; 2017 Dec; 141():446-459. PubMed ID: 29049963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New chemical scaffolds for human african trypanosomiasis lead discovery from a screen of tyrosine kinase inhibitor drugs.
    Behera R; Thomas SM; Mensa-Wilmot K
    Antimicrob Agents Chemother; 2014; 58(4):2202-10. PubMed ID: 24468788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicinal Chemistry Optimization of a Diaminopurine Chemotype: Toward a Lead for
    Singh B; Diaz-Gonzalez R; Ceballos-Perez G; Rojas-Barros DI; Gunaganti N; Gillingwater K; Martinez-Martinez MS; Manzano P; Navarro M; Pollastri MP
    J Med Chem; 2020 Sep; 63(17):9912-9927. PubMed ID: 32786222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protozoan Parasite Growth Inhibitors Discovered by Cross-Screening Yield Potent Scaffolds for Lead Discovery.
    Devine W; Woodring JL; Swaminathan U; Amata E; Patel G; Erath J; Roncal NE; Lee PJ; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Pollastri MP
    J Med Chem; 2015 Jul; 58(14):5522-37. PubMed ID: 26087257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
    Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anilinoquinoline based inhibitors of trypanosomatid proliferation.
    Ferrins L; Sharma A; Thomas SM; Mehta N; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Gillingwater K; Pollastri MP
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006834. PubMed ID: 30475800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirubin Analogues Inhibit
    Efstathiou A; Gaboriaud-Kolar N; Myrianthopoulos V; Vougogiannopoulou K; Subota I; Aicher S; Mikros E; Bastin P; Skaltsounis AL; Soteriadou K; Smirlis D
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of Physicochemical Properties for 4-Anilinoquinoline Inhibitors of Plasmodium falciparum Proliferation.
    Mehta N; Ferrins L; Leed SE; Sciotti RJ; Pollastri MP
    ACS Infect Dis; 2018 Apr; 4(4):577-591. PubMed ID: 29301082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a resazurin-based high-throughput screening assay for the identification and progression of new treatments for human African trypanosomiasis.
    Bowling T; Mercer L; Don R; Jacobs R; Nare B
    Int J Parasitol Drugs Drug Resist; 2012 Dec; 2():262-70. PubMed ID: 24533287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinase scaffold repurposing for neglected disease drug discovery: discovery of an efficacious, lapatinib-derived lead compound for trypanosomiasis.
    Patel G; Karver CE; Behera R; Guyett PJ; Sullenberger C; Edwards P; Roncal NE; Mensa-Wilmot K; Pollastri MP
    J Med Chem; 2013 May; 56(10):3820-32. PubMed ID: 23597080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly improved antiparasitic activity after introduction of an N-benzylimidazole moiety on protein farnesyltransferase inhibitors.
    Bosc D; Mouray E; Cojean S; Franco CH; Loiseau PM; Freitas-Junior LH; Moraes CB; Grellier P; Dubois J
    Eur J Med Chem; 2016 Feb; 109():173-86. PubMed ID: 26774924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of N-(2-aminoethyl)-N-benzyloxyphenyl benzamides: New potent Trypanosoma brucei inhibitors.
    Buchynskyy A; Gillespie JR; Hulverson MA; McQueen J; Creason SA; Ranade RM; Duster NA; Gelb MH; Buckner FS
    Bioorg Med Chem; 2017 Mar; 25(5):1571-1584. PubMed ID: 28187957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New C2- and N3-Modified Thieno[2,3-d]Pyrimidine Conjugates with Cytotoxicity in the Nanomolar Range.
    Mavrova AT; Dimov S; Yancheva D; Rangelov M; Wesselinova D; Naydenova E
    Anticancer Agents Med Chem; 2022; 22(6):1201-1212. PubMed ID: 34315388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Trypanosoma brucei AdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based Assay.
    Volkov OA; Cosner CC; Brockway AJ; Kramer M; Booker M; Zhong S; Ketcherside A; Wei S; Longgood J; McCoy M; Richardson TE; Wring SA; Peel M; Klinger JD; Posner BA; De Brabander JK; Phillips MA
    ACS Infect Dis; 2017 Jul; 3(7):512-526. PubMed ID: 28350440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp.
    Scarim CB; Chelucci RC; Dos Santos JL; Chin CM
    Med Chem; 2020; 16(1):24-38. PubMed ID: 31218962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bis(2-aminoimidazolines) and Bisguanidines: Synthetic Approaches, Antiparasitic Activity and DNA Binding Properties.
    Dardonville C; Martínez JJN
    Curr Med Chem; 2017; 24(33):3606-3632. PubMed ID: 28641558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.